| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.907 | 0.001 | 0.912 | Hepatoprotectant | 0.912 0.001 DBMET02057 | DBMET02057 | |
| 0.898 | 0.005 | 0.928 | Antiinflammatory | 0.928 0.005 DBMET02057 | DBMET02057 | |
| 0.894 | 0.006 | 0.911 | Apoptosis agonist | 0.911 0.005 DBMET02057 | DBMET02057 | |
| 0.839 | 0.001 | 0.855 | Histone deacetylase stimulant | 0.855 0.001 DBMET02057 | DBMET02057 | |
| 0.839 | 0.001 | 0.855 | Histone deacetylase SIRT1 stimulant | 0.855 0.001 DBMET02057 | DBMET02057 | |
| 0.807 | 0.004 | 0.903 | Antioxidant | 0.903 0.004 DBMET02057 | DBMET02057 | |
| 0.792 | 0.003 | 0.83 | Cyclooxygenase 1 inhibitor | 0.83 0.003 DBMET02057 | DBMET02057 | |
| 0.768 | 0.001 | 0.804 | Maillard reaction inhibitor | 0.804 0.001 DBMET02057 | DBMET02057 | |
| 0.763 | 0.003 | 0.773 | Platelet adhesion inhibitor | 0.773 0.003 DBMET02057 | DBMET02057 | |
| 0.738 | 0.003 | 0.769 | Lipid peroxidase inhibitor | 0.769 0.002 DBMET02057 | DBMET02057 | |
| 0.668 | 0.005 | 0.668 | Cardiotonic | 0.659 0.005 DBMET02057 | ||
| 0.674 | 0.024 | 0.723 | Transcription factor NF kappa B inhibitor | 0.723 0.018 DBMET02057 | DBMET02057 | |
| 0.64 | 0.003 | 0.658 | NADPH oxidase inhibitor | 0.658 0.003 DBMET02057 | DBMET02057 | |
| 0.619 | 0.004 | 0.64 | Cyclooxygenase inhibitor | 0.64 0.004 DBMET02057 | DBMET02057 | |
| 0.601 | 0.004 | 0.601 | Non-steroidal antiinflammatory agent | 0.586 0.005 DBMET02057 | ||
| 0.592 | 0.001 | 0.623 | Ca(v)3.1 blocker | 0.623 0.001 DBMET02057 | DBMET02057 | |
| 0.594 | 0.008 | 0.594 | Tumour necrosis factor alpha release inhibitor | 0.532 0.011 DBMET02057 | ||
| 0.598 | 0.017 | 0.598 | Angiogenesis inhibitor | 0.521 0.026 DBMET02057 | ||
| 0.577 | 0.003 | 0.622 | Vanilloid agonist | 0.622 0.003 DBMET02057 | DBMET02057 | |
| 0.569 | 0.056 | 0.569 | Transcription factor inhibitor | 0.517 0.07 DBMET02057 | ||
| 0.538 | 0.028 | 0.667 | Aldehyde oxidase inhibitor | 0.667 0.011 DBMET02057 | DBMET02057 | |
| 0.439 | 0.005 | 0.445 | Cyclooxygenase 2 inhibitor | 0.445 0.005 DBMET02057 | DBMET02057 | |
| 0.476 | 0.046 | 0.582 | 15-Lipoxygenase inhibitor | 0.582 0.026 DBMET02057 | DBMET02057 | |
| 0.43 | 0.004 | 0.43 | Cyclooxygenase 3 inhibitor | 0.425 0.004 DBMET02057 | ||
| 0.426 | 0.005 | 0.426 | Cytokine production inhibitor | 0.343 0.01 DBMET02057 | ||
| 0.458 | 0.051 | 0.473 | Prostaglandin dehydrogenase inhibitor | 0.473 0.048 DBMET02057 | DBMET02057 | |
| 0.391 | 0.027 | 0.436 | Hypolipemic | 0.436 0.019 DBMET02057 | DBMET02057 | |
| 0.356 | 0.019 | 0.356 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.327 0.024 DBMET02057 | ||
| 0.336 | 0.001 | 0.336 | Ryanodine receptor antagonist | 0.251 0.002 DBMET02057 | ||
| 0.362 | 0.047 | 0.43 | Lipoxygenase inhibitor | 0.43 0.03 DBMET02057 | DBMET02057 | |
| 0.306 | 0.004 | 0.316 | Vanilloid 1 agonist | 0.316 0.004 DBMET02057 | DBMET02057 | |
| 0.256 | 0.004 | 0.312 | Histone deacetylase 10 inhibitor | 0.312 0.003 DBMET02057 | DBMET02057 | |
| 0.257 | 0.004 | 0.261 | Histone deacetylase 5 inhibitor | 0.261 0.004 DBMET02057 | DBMET02057 | |
| 0.343 | 0.106 | 0.455 | Antibacterial | 0.455 0.055 DBMET02057 | DBMET02057 | |
| 0.2 | 0.004 | 0.258 | Histone deacetylase class IV inhibitor | 0.258 0.004 DBMET02057 | DBMET02057 | |
| 0.2 | 0.004 | 0.258 | Histone deacetylase 11 inhibitor | 0.258 0.004 DBMET02057 | DBMET02057 | |
| 0.263 | 0.067 | 0.293 | Superoxide dismutase inhibitor | 0.293 0.053 DBMET02057 | DBMET02057 | |
| 0.306 | 0.112 | 0.485 | GABA C receptor rho-3 antagonist | 0.485 0.03 DBMET02057 | DBMET02057 | |
| 0.19 | 0.005 | 0.197 | Histone deacetylase class IIa inhibitor | 0.197 0.005 DBMET02057 | DBMET02057 | |
| 0.184 | 0.006 | 0.184 | Histone deacetylase inhibitor | 0.181 0.006 DBMET02057 | ||
| 0.247 | 0.074 | 0.292 | Platelet antagonist | 0.292 0.055 DBMET02057 | DBMET02057 | |
| 0.177 | 0.005 | 0.202 | Histone deacetylase 3 inhibitor | 0.202 0.005 DBMET02057 | DBMET02057 | |
| 0.21 | 0.038 | 0.251 | Protein kinase stimulant | 0.251 0.026 DBMET02057 | DBMET02057 | |
| 0.254 | 0.097 | 0.266 | Hypoxia-inducible factor 1 alpha inhibitor | 0.266 0.087 DBMET02057 | DBMET02057 | |
| 0.167 | 0.012 | 0.167 | Metalloproteinase-9 inhibitor | 0.158 0.014 DBMET02057 | ||
| 0.323 | 0.169 | 0.323 | Caspase 9 stimulant | 0.297 0.197 DBMET02057 | ||
| 0.218 | 0.069 | 0.218 | Platelet aggregation inhibitor | |||
| 0.225 | 0.08 | 0.393 | Free radical scavenger | 0.393 0.03 DBMET02057 | DBMET02057 | |
| 0.235 | 0.097 | 0.255 | 5 Hydroxytryptamine uptake stimulant | 0.255 0.076 DBMET02057 | DBMET02057 | |
| 0.189 | 0.058 | 0.216 | Succinate dehydrogenase inhibitor | 0.216 0.037 DBMET02057 | DBMET02057 | |
| 0.176 | 0.045 | 0.184 | Mannose-6-phosphate isomerase inhibitor | 0.184 0.04 DBMET02057 | DBMET02057 | |
| 0.144 | 0.014 | 0.3 | HIV-1 integrase (3'-Processing) inhibitor | 0.3 0.005 DBMET02057 | DBMET02057 | |
| 0.134 | 0.006 | 0.134 | Histone deacetylase 8 inhibitor | 0.134 0.006 DBMET02057 | ||
| 0.128 | 0.003 | 0.129 | Nitric oxide donor | 0.129 0.003 DBMET02057 | DBMET02057 | |
| 0.26 | 0.136 | 0.26 | Calcium channel activator | |||
| 0.171 | 0.049 | 0.171 | Tubulin antagonist | |||
| 0.127 | 0.006 | 0.133 | Histone deacetylase 7 inhibitor | 0.133 0.005 DBMET02057 | DBMET02057 | |
| 0.12 | 0.005 | 0.14 | Histone deacetylase 4 inhibitor | 0.14 0.005 DBMET02057 | DBMET02057 | |
| 0.117 | 0.007 | 0.125 | Histone deacetylase class II inhibitor | 0.125 0.007 DBMET02057 | DBMET02057 | |
| 0.216 | 0.109 | 0.309 | Tyrosine 3 hydroxylase inhibitor | 0.309 0.029 DBMET02057 | DBMET02057 | |
| 0.107 | 0.01 | 0.114 | Histone deacetylase 2 inhibitor | 0.114 0.009 DBMET02057 | DBMET02057 | |
| 0.197 | 0.102 | 0.197 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.192 0.105 DBMET02057 | ||
| 0.096 | 0.008 | 0.096 | Histone deacetylase class I inhibitor | 0.088 0.009 DBMET02057 | ||
| 0.139 | 0.053 | 0.139 | Cell adhesion inhibitor | 0.13 0.059 DBMET02057 | ||
| 0.087 | 0.007 | 0.115 | Histone deacetylase 9 inhibitor | 0.115 0.005 DBMET02057 | DBMET02057 | |
| 0.155 | 0.075 | 0.447 | Peroxidase inhibitor | 0.447 0.015 DBMET02057 | DBMET02057 | |
| 0.149 | 0.075 | 0.166 | GABA C receptor rho-2 antagonist | 0.166 0.055 DBMET02057 | DBMET02057 | |
| 0.1 | 0.035 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | 0.08 0.074 DBMET02057 | ||
| 0.115 | 0.05 | 0.14 | Carbonic anhydrase XV inhibitor | 0.14 0.035 DBMET02057 | DBMET02057 | |
| 0.102 | 0.039 | 0.102 | Glutamate release inhibitor | 0.084 0.077 DBMET02057 | ||
| 0.073 | 0.01 | 0.078 | Histone deacetylase 1 inhibitor | 0.078 0.009 DBMET02057 | DBMET02057 | |
| 0.247 | 0.185 | 0.408 | Analgesic | 0.408 0.081 DBMET02057 | DBMET02057 | |
| 0.064 | 0.009 | 0.071 | Histone deacetylase class IIb inhibitor | 0.071 0.009 DBMET02057 | DBMET02057 | |
| 0.063 | 0.009 | 0.069 | Histone deacetylase 6 inhibitor | 0.069 0.009 DBMET02057 | DBMET02057 | |
| 0.082 | 0.03 | 0.197 | HIV-1 integrase (Strand Transfer) inhibitor | 0.197 0.01 DBMET02057 | DBMET02057 | |
| 0.173 | 0.127 | 0.173 | 5 Hydroxytryptamine 3E antagonist | 0.164 0.155 DBMET02057 | ||
| 0.111 | 0.065 | 0.111 | Acetylcholine release stimulant | |||
| 0.162 | 0.123 | 0.188 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.188 0.083 DBMET02057 | DBMET02057 | |
| 0.179 | 0.142 | 0.197 | 5 Hydroxytryptamine release stimulant | 0.197 0.124 DBMET02057 | DBMET02057 | |
| 0.134 | 0.099 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.15 0.044 DBMET02057 | DBMET02057 | |
| 0.068 | 0.034 | 0.068 | Transcription factor RelA inhibitor | 0.061 0.051 DBMET02057 | ||
| 0.064 | 0.033 | 0.064 | Calcium channel T-type blocker | |||
| 0.104 | 0.073 | 0.174 | Cystathionine beta-synthase inhibitor | 0.174 0.032 DBMET02057 | DBMET02057 | |
| 0.096 | 0.066 | 0.157 | Carbonic anhydrase III inhibitor | 0.157 0.026 DBMET02057 | DBMET02057 | |
| 0.106 | 0.076 | 0.106 | Calcium channel (voltage-sensitive) blocker | |||
| 0.118 | 0.09 | 0.118 | Calcium channel blocker | |||
| 0.129 | 0.104 | 0.169 | Adenylate cyclase stimulant | 0.169 0.037 DBMET02057 | DBMET02057 | |
| 0.057 | 0.032 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.06 0.025 DBMET02057 | DBMET02057 | |
| 0.101 | 0.077 | 0.167 | Protein-tyrosine phosphatase 1B inhibitor | 0.167 0.039 DBMET02057 | DBMET02057 | |
| 0.038 | 0.015 | 0.038 | Melatonin receptor 1A agonist | |||
| 0.058 | 0.038 | 0.228 | Alcohol oxidase inhibitor | 0.228 0.005 DBMET02057 | DBMET02057 | |
| 0.037 | 0.019 | 0.045 | HMG CoA reductase inhibitor | 0.045 0.01 DBMET02057 | DBMET02057 | |
| 0.084 | 0.068 | 0.139 | Triose-phosphate isomerase inhibitor | 0.139 0.023 DBMET02057 | DBMET02057 | |
| 0.169 | 0.154 | 0.186 | Nitric-oxide synthase stimulant | 0.186 0.115 DBMET02057 | DBMET02057 | |
| 0.066 | 0.051 | 0.066 | Glutamate (mGluR7) antagonist | |||
| 0.066 | 0.052 | 0.066 | Exportin-1 inhibitor | |||
| 0.048 | 0.035 | 0.066 | Dopamine beta hydroxylase inhibitor | 0.066 0.01 DBMET02057 | DBMET02057 | |
| 0.123 | 0.11 | 0.192 | Protein-tyrosine phosphatase inhibitor | 0.192 0.05 DBMET02057 | DBMET02057 | |
| 0.195 | 0.183 | 0.241 | Antithrombotic | 0.241 0.133 DBMET02057 | DBMET02057 | |
| 0.07 | 0.059 | 0.071 | CYP2A6 inhibitor | 0.071 0.058 DBMET02057 | DBMET02057 | |
| 0.079 | 0.07 | 0.1 | D-Ala-D-Ala ligase inhibitor | 0.1 0.029 DBMET02057 | DBMET02057 | |
| 0.136 | 0.128 | 0.136 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.083 | 0.076 | 0.095 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.095 0.059 DBMET02057 | DBMET02057 | |
| 0.125 | 0.12 | 0.16 | Arachidonic acid antagonist | 0.16 0.077 DBMET02057 | DBMET02057 | |
| 0.062 | 0.059 | 0.072 | Glutamate (mGluR6) antagonist | 0.072 0.036 DBMET02057 | DBMET02057 | |
| 0.126 | 0.123 | 0.145 | Melanin inhibitor | 0.145 0.089 DBMET02057 | DBMET02057 | |
| 0.046 | 0.043 | 0.051 | Squalene epoxidase inhibitor | 0.051 0.032 DBMET02057 | DBMET02057 | |
| 0.065 | 0.063 | 0.086 | Carbonic anhydrase XIII inhibitor | 0.086 0.046 DBMET02057 | DBMET02057 | |
| 0.031 | 0.028 | 0.115 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.115 0.005 DBMET02057 | DBMET02057 | |
| 0.077 | 0.08 | 0.095 | Estrogen-related receptor beta agonist | 0.095 0.032 DBMET02057 | DBMET02057 | |
| 0.077 | 0.083 | 0.104 | NADH dehydrogenase inhibitor | 0.104 0.04 DBMET02057 | DBMET02057 | |
| 0.087 | 0.095 | 0.118 | Beta glucuronidase inhibitor | 0.118 0.048 DBMET02057 | DBMET02057 | |
| 0.08 | 0.09 | 0.148 | UDP-glucose 4-epimerase inhibitor | 0.148 0.029 DBMET02057 | DBMET02057 | |
| 0.04 | 0.053 | 0.056 | Glucose-6-phosphate isomerase inhibitor | 0.056 0.022 DBMET02057 | DBMET02057 | |
| 0.234 | 0.251 | 0.264 | 5 Hydroxytryptamine release inhibitor | 0.264 0.209 DBMET02057 | DBMET02057 | |
| 0.054 | 0.077 | 0.206 | Porphobilinogen synthase inhibitor | 0.206 0.011 DBMET02057 | DBMET02057 | |
| 0.056 | 0.08 | 0.087 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.087 0.046 DBMET02057 | DBMET02057 | |
| 0.063 | 0.087 | 0.098 | Carbonic anhydrase VI inhibitor | 0.098 0.04 DBMET02057 | DBMET02057 | |
| 0.054 | 0.081 | 0.135 | Glutamate decarboxylase inhibitor | 0.135 0.016 DBMET02057 | DBMET02057 | |
| 0.069 | 0.096 | 0.135 | 5-Lipoxygenase inhibitor | 0.135 0.044 DBMET02057 | DBMET02057 | |
| 0.125 | 0.153 | 0.134 | Heat shock protein 70 antagonist | 0.134 0.099 DBMET02057 | DBMET02057 | |
| 0.082 | 0.111 | 0.116 | Adenylate kinase inhibitor | 0.116 0.047 DBMET02057 | DBMET02057 | |
| 0.168 | 0.198 | 0.227 | Cholesterol antagonist | 0.227 0.143 DBMET02057 | DBMET02057 | |
| 0.071 | 0.104 | 0.211 | Creatine kinase inhibitor | 0.211 0.009 DBMET02057 | DBMET02057 | |
| 0.049 | 0.082 | 0.064 | Carbonic anhydrase VA inhibitor | 0.064 0.053 DBMET02057 | DBMET02057 | |
| 0.084 | 0.117 | 0.141 | DOPA decarboxylase inhibitor | 0.141 0.026 DBMET02057 | DBMET02057 | |
| 0.086 | 0.125 | 0.172 | Alpha-N-acetylglucosaminidase inhibitor | 0.172 0.044 DBMET02057 | DBMET02057 | |
| 0.031 | 0.073 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.025 DBMET02057 | DBMET02057 | |
| 0.074 | 0.116 | 0.101 | GABA C receptor rho-1 antagonist | 0.101 0.061 DBMET02057 | DBMET02057 | |
| 0.024 | 0.067 | 0.072 | Dopamine D5 agonist | 0.072 0.008 DBMET02057 | DBMET02057 | |
| 0.029 | 0.072 | 0.062 | Carbonic anhydrase VB inhibitor | 0.062 0.033 DBMET02057 | DBMET02057 | |
| 0.036 | 0.08 | 0.077 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.077 0.018 DBMET02057 | DBMET02057 | |
| 0.079 | 0.124 | 0.133 | Amylase inhibitor | 0.133 0.073 DBMET02057 | DBMET02057 | |
| 0.02 | 0.069 | 0.05 | Estradiol 17 beta-dehydrogenase inhibitor | 0.05 0.025 DBMET02057 | DBMET02057 | |
| 0.009 | 0.058 | 0.023 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.023 0.016 DBMET02057 | DBMET02057 | |
| 0.04 | 0.09 | 0.058 | Carbonic anhydrase V inhibitor | 0.058 0.057 DBMET02057 | DBMET02057 | |
| 0.071 | 0.122 | 0.098 | Xanthine oxidase inhibitor | 0.098 0.061 DBMET02057 | DBMET02057 | |
| 0.038 | 0.093 | 0.092 | Phosphofructokinase-1 inhibitor | 0.092 0.035 DBMET02057 | DBMET02057 | |
| 0.035 | 0.093 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.057 0.038 DBMET02057 | DBMET02057 | |
| 0.033 | 0.092 | 0.046 | Aconitate hydratase inhibitor | 0.046 0.045 DBMET02057 | DBMET02057 | |
| 0.053 | 0.118 | 0.071 | Keratolytic | 0.071 0.062 DBMET02057 | DBMET02057 | |
| 0.064 | 0.13 | 0.137 | GABA C receptor agonist | 0.137 0.039 DBMET02057 | DBMET02057 | |
| 0.103 | 0.171 | 0.134 | Pyruvate kinase inhibitor | 0.134 0.131 DBMET02057 | DBMET02057 | |
| 0.039 | 0.11 | 0.084 | Histidine decarboxylase inhibitor | 0.084 0.04 DBMET02057 | DBMET02057 | |
| 0.144 | 0.217 | 0.205 | 12-Lipoxygenase inhibitor | 0.205 0.146 DBMET02057 | DBMET02057 | |
| 0.077 | 0.151 | 0.123 | Aldehyde dehydrogenase inhibitor | 0.123 0.067 DBMET02057 | DBMET02057 | |
| 0.104 | 0.183 | 0.126 | Interferon gamma antagonist | 0.126 0.12 DBMET02057 | DBMET02057 | |
| 0.03 | 0.11 | 0.059 | Biliverdin reductase inhibitor | 0.059 0.041 DBMET02057 | DBMET02057 | |
| 0.091 | 0.179 | 0.13 | Hexokinase inhibitor | 0.13 0.105 DBMET02057 | DBMET02057 | |
| 0.036 | 0.125 | 0.055 | Purinergic P2X1 antagonist | 0.055 0.051 DBMET02057 | DBMET02057 | |
| 0.035 | 0.126 | 0.054 | Dihydroorotate oxidase inhibitor | 0.054 0.04 DBMET02057 | DBMET02057 | |
| 0.053 | 0.146 | 0.081 | Estrogen receptor alpha antagonist | 0.081 0.048 DBMET02057 | DBMET02057 | |
| 0.059 | 0.158 | 0.097 | Anabolic | 0.097 0.066 DBMET02057 | DBMET02057 | |
| 0.032 | 0.136 | 0.122 | Phenylalanine 4-hydroxylase inhibitor | 0.122 0.018 DBMET02057 | DBMET02057 | |
| 0.042 | 0.146 | 0.073 | Glutamate dehydrogenase inhibitor | 0.073 0.053 DBMET02057 | DBMET02057 | |
| 0.043 | 0.148 | 0.09 | Monophenol monooxygenase inhibitor | 0.09 0.084 DBMET02057 | DBMET02057 | |
| 0.061 | 0.171 | 0.112 | GABA C receptor antagonist | 0.112 0.061 DBMET02057 | DBMET02057 | |
| 0.044 | 0.16 | 0.103 | Aminopeptidase B inhibitor | 0.103 0.063 DBMET02057 | DBMET02057 | |
| 0.145 | 0.265 | 0.213 | Insulysin inhibitor | 0.213 0.139 DBMET02057 | DBMET02057 | |
| 0.038 | 0.173 | 0.094 | Somatostatin 1 agonist | 0.094 0.038 DBMET02057 | DBMET02057 | |
| 0.15 | 0.286 | 0.211 | Histamine release inhibitor | 0.211 0.19 DBMET02057 | DBMET02057 | |
| 0.052 | 0.192 | 0.084 | MAP kinase kinase 7 inhibitor | 0.084 0.037 DBMET02057 | DBMET02057 | |
| 0.126 | 0.27 | 0.166 | RNA-directed DNA polymerase inhibitor | 0.166 0.16 DBMET02057 | DBMET02057 | |
| 0.101 | 0.253 | 0.149 | Phospholipase C inhibitor | 0.149 0.108 DBMET02057 | DBMET02057 | |
| 0.041 | 0.211 | 0.104 | Topoisomerase II inhibitor | 0.104 0.082 DBMET02057 | DBMET02057 | |
| 0.032 | 0.229 | 0.086 | Alcohol dehydrogenase inhibitor | 0.086 0.069 DBMET02057 | DBMET02057 | |
| 0.085 | 0.291 | 0.146 | Neurotrophic factor enhancer | 0.146 0.144 DBMET02057 | DBMET02057 | |
| 0.003 | 0.255 | 0.045 | Estrogen receptor alpha agonist | 0.045 0.019 DBMET02057 | DBMET02057 | |
| 0.036 | 0.303 | 0.146 | Estrogen receptor beta antagonist | 0.146 0.016 DBMET02057 | DBMET02057 | |
| 0.129 | 0.403 | 0.244 | Cyclophilin D inhibitor | 0.244 0.22 DBMET02057 | DBMET02057 | |
| 0.006 | 0.298 | 0.052 | Estrogen agonist | 0.052 0.034 DBMET02057 | DBMET02057 | |
| 0.023 | 0.318 | 0.069 | HIV-1 integrase inhibitor | 0.069 0.05 DBMET02057 | DBMET02057 | |
| 0.003 | 0.309 | 0.049 | Estrogen receptor beta agonist | 0.049 0.019 DBMET02057 | DBMET02057 | |
| 0.011 | 0.36 | 0.034 | Estrogen-related receptor beta antagonist | 0.034 0.019 DBMET02057 | DBMET02057 | |
| 0.036 | 0.394 | 0.148 | Estrogen antagonist | 0.148 0.024 DBMET02057 | DBMET02057 | |
| 0.05 | 0.437 | 0.134 | NOS3 expression enhancer | 0.134 0.091 DBMET02057 | DBMET02057 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |